EP2004789A1 - A stabilized liquid enzyme composition - Google Patents

A stabilized liquid enzyme composition

Info

Publication number
EP2004789A1
EP2004789A1 EP07727559A EP07727559A EP2004789A1 EP 2004789 A1 EP2004789 A1 EP 2004789A1 EP 07727559 A EP07727559 A EP 07727559A EP 07727559 A EP07727559 A EP 07727559A EP 2004789 A1 EP2004789 A1 EP 2004789A1
Authority
EP
European Patent Office
Prior art keywords
acid
enzyme
alkyl
composition according
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP07727559A
Other languages
German (de)
French (fr)
Other versions
EP2004789B1 (en
Inventor
Lone Kierstein Nielsen
Ole Simonsen
Karl Werntoft
Niclas Ilestam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Priority to EP20110175251 priority Critical patent/EP2383330A1/en
Publication of EP2004789A1 publication Critical patent/EP2004789A1/en
Application granted granted Critical
Publication of EP2004789B1 publication Critical patent/EP2004789B1/en
Not-in-force legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38663Stabilised liquid enzyme compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2075Carboxylic acids-salts thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/20Organic compounds containing oxygen
    • C11D3/2075Carboxylic acids-salts thereof
    • C11D3/2086Hydroxy carboxylic acids-salts thereof
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/24Organic compounds containing halogen
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • C11D3/30Amines; Substituted amines ; Quaternized amines

Definitions

  • the present invention relates to a liquid composition, comprising an enzyme and an enzyme stabilizer.
  • the invention further relates to the use of said liquid composition.
  • acetamidophenyl boronic acid is claimed to be a superior inhibitor of proteolytic enzymes (see WO 92/19707).
  • substituted phenyl boronic acids are disclosed as suitable enzyme stabilizers. It has been found that borates are reprotoxic in animals and therefore there is a demand to find alternatives which can be used to stabilize the enzymes in liquid compositions.
  • the liquid composition does not comprise borate or boric acid.
  • an enzyme stabilization system comprising carboxylic acids for aqueous liquid detergent compositions is disclosed.
  • One object of the present invention is to provide a stable liquid composition.
  • aryl carboxylic acids have extraordinary good capacities as enzyme stabilizers in liquids, especially of the following formula:
  • R 1 is selected from the group consisting of CO, C1 , C2, C3, C4, C5 alkyl, substituted C1 , C2, C3, C4, C5 alkyl, C1 , C2, C3, C4, C5 alkenyl and substituted C1 , C2, C3, C4, C5, alkenyl and R 2 , R3, R 4 , R5 and Re is selected from the group consisting of hydrogen, C1 , C2, C3, C4, C5, C6 alkyl, substituted C1 , C2, C3, C4, C5, C6 alkyl, aryl, sub- stituted aryl, hydroxyl, hydroxyl derivative, amine, C1 , C2, C3, C4, C5, C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phosphonate.
  • the present invention provides thus in a first aspect a liquid composition
  • a liquid composition comprising an enzyme and an enzyme stabilizer of the following formula:
  • R 1 is selected from the group consisting of C0-C5 alkyl, substituted C1-C5 alkyl, C1-C5 alkenyl and substituted C1-C6 alkenyl and R 2 , R 3 , R 4 , Rs and R 6 is selected from the group consisting of hydrogen, C1-C6 alkyl, substituted C1 to C6 alkyl, aryl, substituted aryl, hydroxyl, hydroxyl derivative, amine, C1-C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phos- phonate.
  • the present invention relates to stabilization of enzymes in liquid compositions.
  • the present invention provides a liquid composition comprising an enzyme and an enzyme stabilizer of the following formula:
  • R 1 is selected from the group consisting of C0-C5 alkyl, substituted C1-C5 alkyl, C1-C5 alkenyl and substituted C1-C6 alkenyl.
  • R 1 is CH 2 , CH 2 -CH 2 , CH 2 -CH 2 -CH 2 or CH 2 -CH 2 -CH 2 -CH 2 .
  • R 1 is CO, CH 2 or CH 2 -CH 2
  • R 2 , R 3 , R 4 , R 5 and/or R 6 is selected from the group consisting of hydrogen, C1 , C2, C3, C4, C5, C6 alkyl, substituted C1 , C2, C3, C4, C5, C6 alkyl, aryl, substituted aryl, hydroxyl, hydroxyl derivative, amine, C1 , C2, C3, C4, C5, C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phosphonate.
  • R 2 , R 3 , R 4 , R 5 and/or R 6 is selected from the group consisting of hydrogen, C2, C3, C5, C6 alkyl, substituted C2, C3, C5, C6 alkyl, aryl, substituted aryl, hydroxyl, hydroxyl derivative, amine, C1 , C2, C3, C4, C5, C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phosphonate.
  • R 2 , R 3 , R 4 , R 5 , R 6 is CH 3 , CH 3 CH 2 and/or CH 3 CH 2 CH 2 .
  • the present invention provides a liquid composition comprising an enzyme and an enzyme stabilizer of the formula disclosed above, wherein R 2 and R 6 are hydrogens.
  • At least one of the substituents of R2, R3, R4, R5, R6 are selected from the group consisting of C1 to C6 alkyl, substituted C1 to C6 alkyl, aryl, substituted aryl, C1 to C6 alkyl hydroxyl, hydroxyl derivative, amine, C1-C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate and phosphonate.
  • R2, R3, R4, R5, R6 are selected from the group consisting of C2, C3, C5, C6 alkyl, substituted C5, C6 alkyl, aryl, substituted aryl,C2, C3, C5, C6 alkyl hydroxyl, amine, C1-C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate and phosphonate.
  • the stabilizer is selected from the group consisting of benzoic acid, 3-formylbenzoic acid, 4-formylbenzoic acid, 3-nitrobenzoic acid, 4-nitrobenzoic acid, 3,5-dinitrobenzoic acid, 3,4-dinitrobenzoic acid, 3-chlorobenzoic acid, 4-chlorobenzoic acid, 3,5-dichlorobenzoic acid, 3,4-dichlorobenzoic acid, 3-chloromethylbenzoic acid, 4- chloromethyl benzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, 3,5-diaminobenzoic acid, 3,4-diaminobenzoic acid, 3-aminomethylbenzoic acid, 4-aminomethylbenzoic acid, 3- hydroxybenzoic acid, 4-hydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 3,4- dihydroxybenzoic acid, 4-hydroxy-3-methoxybenzoic acid (vanillic acid), phenylacetic acid, 3-
  • aldehydes of the below formula also are particularly well suited as stabilizers in liquid compositions comprising an enzyme.
  • the aldehydes have the following formula:
  • R 1 is selected from the group consisting of C0-C5 alkyl, substituted C1-C5 alkyl, C1-C5 alkenyl and substituted C1-C6 alkenyl.
  • R 1 is CH 2 , CH 2 -CH 2 , CH 2 -CH 2 -CH 2 or CH 2 -CH 2 -CH 2 -CH 2 .
  • R 1 is CO, CH 2 or CH 2 -CH 2
  • R 2 , R3, R 4 , R 5 and/or R 6 is selected from the group consisting of hydrogen, C1 , C2, C3, C4, C5, C6 alkyl, substituted C1 , C2, C3, C4, C5, C6 alkyl, aryl, substituted aryl, hydroxyl, hydroxyl derivative, amine, C1 , C2, C3, C4, C5, C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phosphonate.
  • the R 2 , R 3 , R 4 , R 5 , Re is CH 3 , CH 3 CH 2 and/or CH 3 CH 2 CH 2 .
  • the present invention provides a liquid composition comprising an enzyme and an enzyme stabilizer of the formula disclosed above, wherein R 2 and R 6 are hydrogens.
  • At least one of the substituents of R2, R3, R4, R5, R6 are selected from the group consisting of C1 to C6 alkyl, substituted C1 to C6 alkyl, aryl, substituted aryl, C1 to C6 alkyl hydroxyl, hydroxyl derivative, amine, C1-C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate and phosphonate.
  • R2, R3, R4, R5, R6 are selected from the group consisting of C2, C3, C5, C6 alkyl, substituted C5, C6 alkyl, aryl, sub- stituted aryl,C2, C3, C5, C6 alkyl hydroxyl, amine, C1-C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate and phosphonate.
  • the stabilizer is selected from the group consisting of Benzalde- hyde, Phenyl acetaldehyde, Phenyl propionaldehyde, 3,5-dichorobenzaldehyde, 4-formyl- benzaldehyde, 4-carboxybenzaldehyde, 3-chlorobenzaldehyde, 4-chlorobenzaldehyde, 3-(3- chlorophenyl)propionaldehyde, 3-chlorophenylacetaldehyde, 3-(4-chlorophenyl)propion- aldehyde, 4-chlorophenylacetaldehyde, 2-chlorophenylacetaldehyde, 2-chlorophenylacetaldehyde, 2-chlorobenzaldehyde, 2-aminobenzaldehyde, 3-aminobenzaldehyde, 4-aminobenzaldehyde, 3- bromobenzaldehyde, 3-iodobenzal
  • the enzyme stabilizer is substituted in its 3, 4 and/or 5 position. In a more particular embodiment the enzyme stabilizer is substituted in its 4 position i.e. para- substituted. In a most particular embodiment the enzyme stabilizer is substituted in its 3 and/or 5 positions.
  • the liquid composition comprises 0.001- 20% w/w of the stabilizer. In a more particular embodiment of the present invention the liquid composition comprises 0.01-15% of the stabilizer. In an even more particular embodiment of the present invention the liquid composition comprises 0.1-10% w/w of the stabilizer. In a most particular embodiment of the present invention the liquid composition comprises 0.5-5 % of the stabilizer. In a further particular embodiment of the present invention the liquid composition comprises 1.5 to 5% w/w of the stabilizer.
  • the liquid composition comprises 0.05- 1000 imM of the stabilizer. In a more particular embodiment of the present invention the liquid composition comprises 0.5-750 mM of the stabilizer. In an even more particular embodiment of the present invention the liquid composition comprises 5-500 mM of the stabilizer. In a most particular embodiment of the present invention the liquid composition comprises 25-250 mM of the stabilizer. In a particular embodiment the present invention provides a liquid detergent composition comprising a surfactant, an enzyme and an enzyme stabilizer of any of the formulas disclosed above.
  • the stabilizer also have a stabilizing effect at pH above 8 such as above 9. Active compounds
  • the liquid composition contains at least one enzyme.
  • the enzyme may be any commercially available enzyme, in particular an enzyme selected from the group consisting of proteases, amylases, lipases, cellulases, lyases, oxidoreductases and any mixture thereof. Mixtures of enzymes from the same class (e.g. proteases) are also included.
  • the liquid composition comprises more than 2 different enzymes.
  • a liquid composition comprising a protease is preferred.
  • a liquid composition comprising two or more enzymes in which the first enzyme is a protease and the second enzyme is selected from the group consisting of amylases, lipases, cellulases, lyases and oxidoreductases is preferred.
  • the second enzyme is a lipase.
  • enzyme variants are included within the meaning of the term "enzyme”. Examples of such enzyme variants are disclosed, e.g. in EP 251 ,446 (Genencor), WO 91/00345 (Novozymes),
  • EP 525,610 Solvay
  • WO 94/02618 Gist-Brocades NV
  • Enzymes can be classified on the basis of the handbook Enzyme Nomenclature from NC-
  • ENZYME is a repository of information relative to the nomenclature of enzymes. It is primarily based on the recommendations of the Nomenclature Committee of the International Union of
  • IUB-MB Biochemistry and Molecular Biology
  • Academic Press, Inc. 1992, and it describes each type of characterized enzyme for which an EC (Enzyme Commission) number has been provided (Bairoch A. The ENZYME database, 2000, Nucleic Acids Res 28:304-305).
  • This IUB-MB Enzyme nomenclature is based on their substrate specificity and occasionally on their molecular mechanism; such a classification does not reflect the structural features of these enzymes.
  • glycoside hydrolase enzymes such as endoglucanase, xy- lanase, galactanase, mannanase, dextranase and alpha-galactosidase, in families based on amino acid sequence similarities has been proposed a few years ago. They currently fall into
  • the liquid composition preferably comprises a protease, such as a serine protease.
  • protease such as a serine protease.
  • proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically or genetically modified mutants are included.
  • the protease may be a serine protease, preferably an alkaline microbial protease or a trypsin-like protease.
  • al-kaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279).
  • trypsin-like proteases are tryp-sin (e.g. of porcine or bovine origin) and the Fusarium pro-tease described in WO 89/06270.
  • the protease is a serine protease.
  • Serine proteases or serine endopeptidases are a class of peptidases which are characterised by the presence of a serine residue in the active center of the enzyme.
  • a serine protease is an enzyme which catalyzes the hydrolysis of peptide bonds, and in which there is an essential serine residue at the active site (White, Handler and Smith, 1973 "Principles of Biochemistry," Fifth Edition, McGraw-Hill Book Company, NY, pp. 271-272).
  • the bacterial serine proteases have molecular weights in the 20,000 to 45,000 Daltons range. They are inhibited by diisopropylfluorophosphate. They hydrolyze simple terminal esters and are similar in activity to eukaryotic chymotrypsin, also a serine protease.
  • subtilisin A sub-group of the serine proteases tentatively designated subtilases has been proposed by Siezen et al. (1991 ), Protein Eng., 4 719-737. They are defined by homology analysis of more than 40 amino acid sequences of serine proteases previously referred to as subtilisin-like proteases. A subtilisin was previously defined as a serine protease produced by Gram-positive bacteria or fungi, and according to Siezen et al.
  • subtilisins A wide variety of subtilisins have been identified, and the amino acid sequence of a number of subtilisins have been determined. These include more than six subtilisins from Bacillus strains, namely, subtilisin 168, subtilisin BPN', subtilisin Carlsberg, subtilisin Y, subtilisin amylosacchariticus, and mesentericopeptidase (Kurihara et al. (1972) J. Biol. Chem. 247 5629-5631 ; Wells et al. (1983) Nucleic Acids Res. 11 791 1-7925; Stahl and Ferrari (1984) J. Bacteriol. 159 81 1-819, Jacobs et al.
  • subtilisins are well-characterized physically and chemically. In addition to knowledge of the primary structure (amino acid sequence) of these enzymes, over 50 high resolution X-ray structures of subtilisins have been determined which delineate the binding of substrate, transition state, products, at least three different protease inhibitors, and define the structural consequences for natural variation (Kraut (1977) Ann. Rev. Biochem. 46 331-358).
  • One subgroup of the subtilases, I-S1 comprises the "classical" subtilisins, such as subtilisin 168, subtilisin BPN', subtilisin Carlsberg (ALCALASE®, Novozymes A/S), and subtilisin DY.
  • subtilases I-S2 A further subgroup of the subtilases I-S2, is recognised by Siezen et al. (supra).
  • Sub-group I- S2 proteases are described as highly alkaline subtilisins and comprise enzymes such as subtilisin PB92 (MAXACAL®, Gist-Brocades NV), subtilisin 309 (SAVINASE®, Novozymes A/S), subtilisin 147 (ESPERASE®, Novozymes A/S), and alkaline elastase YaB.
  • proteases examples include KannaseTM, EverlaseTM, EsperaseTM, AlcalaseTM, NeutraseTM, DurazymTM, SavinaseTM, OvozymeTM, PyraseTM, Pancreatic Trypsin NOVO (PTN), Bio-FeedTM Pro and Clear-LensTM Pro (all available from Novozymes A/S, Bagsvaerd, Denmark).
  • Other preferred proteases include those described in WO 01/58275 and WO 01/58276.
  • proteases include RonozymeTM Pro, MaxataseTM, MaxacalTM, MaxapemTM, OpticleanTM, PropeaseTM, PurafectTM and Purafect OxTM (available from Genencor International Inc., Gist-Brocades, BASF, or DSM Nutritional Products).
  • Lipases Suitable lipases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included.
  • useful lipases include a Humicola lanugi-nosa lipase, e.g., as described in EP 258 068 and EP 305 216, a Rhizomucor miehei lipase, e.g., as described in EP 238 023, a Candida lipase, such as a C. antarctica lipase, e.g., the C. antarctica lipase A or B described in EP 214 761 , a Pseu-domonas lipase such as a P. pseudoalcaligenes and P. alcali-genes lipase, e.g., as described in EP 218 272, a P.
  • a Humicola lanugi-nosa lipase e.g., as described in EP 258 068 and EP 305 216
  • a Rhizomucor miehei lipase e.g., as described in EP 238 023
  • cepacia lipase e.g., as described in EP 331 376, a P. stutzeri li-pase, e.g., as disclosed in BP 1 ,372,034, a P. fluorescens lipase, a Bacillus lipase, e.g., a B. subtilis lipase (Dar-tois et al., (1993), Biochemica et Biophysica acta 1 131 , 253-260), a B. stearothermophilus lipase (JP 64/744992) and a B. pumilus lipase (WO 91/16422).
  • cloned lipases may be useful, including the Penicillium camenbertii lipase described by Ya-maguchi et al., (1991 ), Gene 103, 61-67), the Geotricum can-didum lipase (Schimada, Y. et al., (1989), J. Biochem. 106, 383-388), and various Rhizopus lipases such as a R. delemar lipase (Hass, MJ et al., (1991 ), Gene 109, 1 17-1 13), a R. niveus lipase (Kugimiya et al., (1992), Biosci. Biotech. Bio-chem. 56, 716-719) and a R. oryzae lipase.
  • R. delemar lipase Hass, MJ et al., (1991 ), Gene 109, 1 17-1 13
  • R. niveus lipase K
  • cutinases may also be useful, e.g., a cutinase derived from Pseudomonas mendocina as described in WO 88/09367, or a cutinase derived from Fusarium solani pisi (e.g. described in WO 90/09446).
  • lipases examples include LipexTM, LipoprimeTM, LipopanTM, LipolaseTM, LipolaseTM Ultra, LipozymeTM, PalataseTM, ResinaseTM, NovozymTM 435 and LecitaseTM (all available from Novozymes A/S).
  • Other commercially available lipases include LumafastTM (Pseudomonas mendocina lipase from Genencor International Inc.); LipomaxTM (Ps. pseudoalcaligenes lipase from Gist- Brocades/Genencor Int. Inc.; and Bacillus sp. lipase from Solvay enzymes.
  • Amylases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included. Amylases include, for example, a- amylases obtained from a special strain of B. licheniformis, described in more detail in British Patent Specification No. 1 ,296,839. Commercially available amylases are DuramylTM, TermamylTM, FungamylTM and BANTM (available from Novozymes A/S) and RapidaseTM and Maxamyl PTM (available from Gist-Brocades).
  • Suitable cellulases include those of bacterial or fungal origin. Chemically or genetically modified mu-tants are included. Suitable cellulases are disclosed in US 4,435,307, which discloses fungal cellulases produced from Humicola insolens. Especially suitable cellulases are the cellulases having color care benefits. Examples of such cellulases are cellulases described in European patent application No. 0 495 257.
  • Oxidoreductases Any oxidoreductase suitable for use in a liquid composition, e.g., peroxidases or oxidases such as laccases, can be used herein. Suitable peroxidases herein include those of plant, bacterial or fungal origin.
  • Suitable peroxidases are those derived from a strain of Coprinus, e.g., C. cinerius or C. macrorhizus, or from a strain of Bacillus, e.g., B. pumilus, particularly peroxidase according to WO 91/05858.
  • Suitable laccases herein include those of bacterial or fungal origin.
  • Chemically or genetically modified mutants are included. Examples of suitable laccases are those obtainable from a strain of Trametes, e.g., T. villosa or T. versicolor, or from a strain of Coprinus, e.g., C. cinereus, or from a strain of Myceliophthora, e.g., M. thermophila.
  • the types of enzymes which may be present in the liquid of the invention include oxidoreductases (EC 1.-.-.-), transferases (EC 2.-.-.-), hydrolases (EC 3.-.-.-), lyases (EC 4.-.- .-), isomerases (EC 5.-.-.-) and ligases (EC 6.-.-.-).
  • Preferred oxidoreductases in the context of the invention are peroxidases (EC 1.11.1 ), laccases (EC 1.10.3.2) and glucose oxidases (EC 1.1.3.4)].
  • An Example of a commercially available oxidoreductase (EC 1.-.-.-) is GluzymeTM (enzyme available from Novozymes A/S). Further oxidoreductases are available from other suppliers.
  • Preferred transferases are transferases in any of the following sub-classes: a Transferases transferring one-carbon groups (EC 2.1 ); b transferases transferring aldehyde or ketone residues (EC 2.2); acyltransferases (EC 1.11.1 ), laccases (EC 1.10.3.2) and glucose oxidases (EC 1.1.3.4)].
  • An Example of a commercially available oxidoreductase (EC 1.-.-.-) is GluzymeTM (enzyme available from Novozymes A/S
  • a most preferred type of transferase in the context of the invention is a transglutaminase (protein-glutamine ⁇ -glutamyltransferase; EC 2.3.2.13). Further examples of suitable transglutaminases are described in WO 96/06931 (Novozymes A/S).
  • Preferred hydrolases in the context of the invention are: carboxylic ester hydrolases (EC 3.1.1.-) such as lipases (EC 3.1.1.3); phytases (EC 3.1.3.-), e.g. 3-phytases (EC 3.1.3.8) and 6-phytases (EC 3.1.3.26); glycosidases (EC 3.2, which fall within a group denoted herein as "carbohydrases”), such as ⁇ -amylases (EC 3.2.1.1 ); peptidases (EC 3.4, also known as proteases); and other carbonyl hydrolases.
  • carboxylic ester hydrolases EC 3.1.1.-
  • phytases EC 3.1.3.-
  • 3-phytases EC 3.1.3.8
  • 6-phytases EC 3.1.3.26
  • glycosidases EC 3.2, which fall within a group denoted herein as "carbohydrases”
  • ⁇ -amylases
  • phytases examples include Bio-FeedTM Phytase (Novozymes), RonozymeTM P (DSM Nutritional Products), NatuphosTM (BASF), FinaseTM (AB Enzymes), and the PhyzymeTM product series (Danisco).
  • Other preferred phytases include those described in WO 98/28408, WO 00/43503, and WO 03/066847.
  • carbohydrase is used to denote not only enzymes capable of breaking down carbohydrate chains (e.g. starches or cellulose) of especially five- and six- membered ring structures (i.e. glycosidases, EC 3.2), but also enzymes capable of isomerizing carbohydrates, e.g. six-membered ring structures such as D-glucose to five- membered ring structures such as D-fructose.
  • Carbohydrases of relevance include the following (EC numbers in parentheses): ⁇ -amylases (EC 3.2.1.1 ), ⁇ -amylases (EC 3.2.1.2), glucan 1 ,4- ⁇ -glucosidases (EC 3.2.1.3), endo-1 ,4-beta-glucanase (cellulases, EC 3.2.1.4), endo-1 ,3(4)- ⁇ -glucanases (EC 3.2.1.6), endo-1 ,4- ⁇ -xylanases (EC 3.2.1.8), dextranases (EC 3.2.1.11 ), chitinases (EC 3.2.1.14), polygalacturonases (EC 3.2.1.15), lysozymes (EC 3.2.1.17), ⁇ -glucosidases (EC 3.2.1.21 ), ⁇ - galactosidases (EC 3.2.1.22), ⁇ -galactosidases (EC 3.2.1.23), amyl
  • carbohydrases examples include Alpha-GalTM, Bio-FeedTM Alpha, Bio-FeedTM Beta, Bio-FeedTM Plus, Bio-FeedTM Wheat, Bio-FeedTM Z, NovozymeTM 188, CarezymeTM, CelluclastTM, CellusoftTM, CelluzymeTM, CeremylTM, CitrozymTM, DenimaxTM, DezymeTM, DextrozymeTM, DuramylTM, EnergexTM, FinizymTM, FungamylTM, GamanaseTM, GlucanexTM, LactozymTM, LiquezymeTM, MaltogenaseTM, NatalaseTM, PentopanTM, PectinexTM, PromozymeTM, PulpzymeTM, NovamylTM, TermamylTM, AMGTM (Amyloglucosidase Novo), MaltogenaseTM, SweetzymeTM and AquazymTM (all available from Novozymes A/S).
  • carbohydrases are available from other suppliers, such as the RoxazymeTM and RonozymeTM product series (DSM Nutritional Products), the AvizymeTM, PorzymeTM and GrindazymeTM product series (Danisco, Finnfeeds), and NatugrainTM (BASF) , PurastarTM and PurastarTM OxAm (Genencor).
  • composition may be any composition, but particularly suitable compositions are cleaning compositions, personal care compositions, textile processing compositions e.g. bleaching, pharmaceutical compositions, leather processing compositions, pulp or paper processing compositions, food and beverage compositions and animal feed compositions.
  • the liquid composition is a liquid detergent, e.g. laundry detergent or dishwashing detergent.
  • the composition comprises a surfactant.
  • the invention is further directed to the use of the liquid enzyme additive in liquid detergent composition.
  • the liquid composition may be a concentrated product to be added to liquid detergents.
  • the amount of enzyme used in the liquid composition is thus very high.
  • the amount of enzyme present in the liquid composition is at least 1.5 g/L.
  • the amount of enzyme is at least 5 g/L.
  • the amount of enzyme present is at least 10 g/L.
  • the amount of enzyme present is at least 20 g/L such as even above 25 g/L.
  • the amount of enzyme does not exceed 200 g/L.
  • the amount of enzyme does not exceed 150 g/L.
  • the amount of enzyme present in the liquid composition is less than 100 g/L.
  • the liquid composition has a pH of more than 7.5. In a more particular embodiment the pH of the liquid composition is at least 7.7. In a most particular embodiment the pH of the liquid composition is at least 8.0. In a most particular embodiment of the present invention the liquid composition contain one or more detergent builders. In a particular embodiment of the present invention the liquid composition comprises at least 1 % w/w of detergent builders. In a more particular embodiment of the present invention the liquid composition comprises at least 2% w/w of detergent builders. In a most particular embodiment of the present invention the liquid composition comprises at least 5% w/w of detergent builders.
  • the liquid composition is a liquid detergent composition.
  • the liquid composition is a liquid detergent composition for dishwashing or for laundry.
  • the enzyme of the invention may be added to and thus become a component of a detergent composition.
  • the detergent composition of the invention may for example be formulated as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre- treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
  • the detergent composition may comprise one or more enzymes such as a protease, a lipase, a cutinase, an amylase, a carbohydrase, a cellulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase, an oxidase, e.g., a laccase, and/or a peroxidase.
  • the properties of the chosen enzyme(s) should be compatible with the selected detergent, (i.e. pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.
  • proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included.
  • the protease may be a serine protease or a metallo protease, preferably an alkaline microbial protease or a trypsin-like protease.
  • alkaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279).
  • trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in WO 89/06270 and WO 94/25583.
  • proteases examples include the variants described in WO 92/19729, WO 98/201 15, WO 98/20116, and WO 98/34946.
  • Preferred commercially available protease enzymes include AlcalaseTM, SavinaseTM, PrimaseTM, DuralaseTM, EsperaseTM, and KannaseTM (Novozymes A/S), MaxataseTM, MaxacalTM, MaxapemTM, ProperaseTM, PurafectTM, Purafect OxPTM, FN2TM, and FN3TM (Genencor International Inc.).
  • Suitable lipases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful lipases include lipases from Humicola (synonym Thermomyces), e.g. from H. lanuginosa (T. lanuginosus) as described in EP 258 068 and EP 305 216 or from H. insolens as described in WO 96/13580, a Pseudomonas lipase, e.g. from P. alcaligenes or P. pseudoalcaligenes (EP 218 272), P. cepacia (EP 331 376), P. stutzeri (GB 1 ,372,034), P.
  • B. stearothermophilus JP 64/744992
  • B. pumilus WO 91/16422.
  • lipase variants such as those described in WO 92/05249, WO 94/01541 , EP 407 225, EP 260 105, WO 95/35381 , WO 96/00292, WO 95/30744, WO 94/25578, WO
  • LipolaseTM and Lipolase UltraTM
  • Amylases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, ⁇ -amylases obtained from Bacillus, e.g. a special strain of B. licheniformis, described in more detail in GB 1 ,296,839.
  • amylases are the variants described in WO 94/02597, WO 94/18314,
  • Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g. the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4,435,307, US 5,648,263, US 5,691 ,178, US 5,776,757 and WO
  • cellulases are the alkaline or neutral cellulases having colour care benefits.
  • Examples of such cellulases are cellulases described in EP 0 495 257, EP 0 531 372, WO 96/1 1262, WO 96/29397, WO 98/08940.
  • Other examples are cellulase variants such as those described in WO 94/07998, EP 0 531 315, US 5,457,046, US 5,686,593, US
  • cellulases Commercially available cellulases include CelluzymeTM, and CarezymeTM (Novozymes A/S),
  • ClazinaseTM and Puradax HATM (Genencor International Inc.), and KAC-500(B)TM (Kao Corporation).
  • Peroxidases/Oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g. from C. cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257. Commercially available peroxidases include GuardzymeTM (Novozymes A/S). The detergent enzyme(s) may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising all of these enzymes.
  • a liquid detergent may be aqueous, typically containing up to 70 % water and 0-30 % organic solvent, or non-aqueous.
  • the detergent composition comprises one or more surfactants, which may be non-ionic including semi-polar and/or anionic and/or cationic and/or zwitterionic.
  • the surfactants are typically present at a level of from 0.1 % to 60% by weight.
  • the detergent will usually contain from about 1 % to about 40% of an ani- onic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
  • an ani- onic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesul
  • the detergent When included therein the detergent will usually contain from about 0.2% to about 40% of a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, al- kyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides").
  • a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, al- kyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides”).
  • glucamides N-acyl N-alkyl derivatives of glucosamine
  • the detergent may contain 0-65 % of a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylenediami- netetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble sili- cates or layered silicates (e.g. SKS-6 from Hoechst).
  • a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylenediami- netetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble sili- cates or layered silicates (e.g. SKS-6 from Hoechst).
  • the detergent may comprise one or more polymers. Examples are carboxymethylcellulose, poly(vinylpyrrolidone), poly (ethylene glycol), polyvinyl alcohol), poly(vinylpyridine-N-oxide), poly(vinylimidazole), polycarboxylates such as polyacrylates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
  • the detergent may contain a bleaching system which may comprise a H 2 O 2 source such as perborate or percarbonate which may be combined with a peracid-forming bleach activator such as tetraacetylethylenediamine or nonanoyloxybenzenesulfonate.
  • the bleaching system may comprise peroxyacids of e.g. the amide, imide, or sulfone type.
  • the enzyme(s) of the detergent composition of the invention may be stabilized using conven- tional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar, sugar alcohol or lactic acid.
  • the liquid composition comprises less than 30 % w/v of polyol, such as less than 25% w/v of polyol or even less than 20% w/v of polyol.
  • the detergent may also contain other conventional detergent ingredients such as e.g. fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil- suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydro- tropes, tarnish inhibitors, or perfumes.
  • fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil- suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydro- tropes, tarnish inhibitors, or perfumes.
  • Enzyme concentration in assay ⁇ 1 x 10 "8 M The initial rate of substrate hydrolysis was determined with and without inhibitor at nine substrate concentrations in the range of 0.01 mM to 2 mM using an automated spectrophotometer.
  • the inhibition constant K was determined using Sigma Plot 9.0, Enzyme Kinetics Module 1.1
  • the inhibition constant K, [E][I]/[EI] for the inhibition of Savinase was determined using standard methods under the following conditions:
  • Buffer 0.1 M phosphate buffer pH 7.5
  • the initial rate of substrate hydrolysis was determined with and without inhibitor at nine sub- strate concentrations in the range of 0.01 mM to 2 mM using an automated spectrophotometer.
  • the inhibition constant K was determined using Sigma Plot 9.0, Enzyme Kinetics Module 1.1
  • the initial rate of substrate hydrolysis was determined with and without inhibitor at nine substrate concentrations in the range of 0.01 mM to 2 mM using an automated spectrophotometer.
  • the inhibition constant K 1 was determined using Sigma Plot 9.0, Enzyme Kinetics Module 1.1

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)

Abstract

The present invention relates to a liquid composition comprising an enzyme and an enzyme stabilizer such as an aryl carboxylic acid.

Description

TITLE: A STABILIZED LIQUID ENZYME COMPOSITION
FIELD OF THE INVENTION
The present invention relates to a liquid composition, comprising an enzyme and an enzyme stabilizer. The invention further relates to the use of said liquid composition.
BACKGROUND OF THE INVENTION
Storage stability problems are well known with liquids containing enzyme(s). Especially in enzyme-containing liquid detergents a major problem, in particular if the detergent contains protease, is that of ensuring enzyme activity over time. The prior art has dealt extensively with improving the storage stability, for example by adding a protease inhibitor.
Boric acid and boronic acids are known to reversibly inhibit proteolytic enzymes. A discussion of the inhibition of one serine protease, subtilisin, by boronic acid is provided in Molecular & Cellular Biochemistry 51 , 1983, pp. 5-32. Boronic acids have very different capacities as subtilisin inhibitors. Boronic acids containing only alkyl groups such as methyl, butyl or 2-cyclohexylethyl are poor inhibitors with methylbo- ronic acid as the poorest inhibitor, whereas boronic acids bearing aromatic groups such as phenyl, 4-methoxyphenyl or 3,5-dichlorophenyl are good inhibitors with 3,5- dichlorophenylboronic acid as a particularly effective one (see Keller et al, Biochem. Biophys. Res. Com. 176, 1991 , pp. 401-405). It is also claimed that aryl boronic acids which have a substitution at the 3-position relative to boron are unexpectedly good reversible protease inhibitors. Especially, acetamidophenyl boronic acid is claimed to be a superior inhibitor of proteolytic enzymes (see WO 92/19707). In WO 96/41859 substituted phenyl boronic acids are disclosed as suitable enzyme stabilizers. It has been found that borates are reprotoxic in animals and therefore there is a demand to find alternatives which can be used to stabilize the enzymes in liquid compositions. In a particular embodiment of the present invention the liquid composition does not comprise borate or boric acid. In EP 0 378 261 B1 an enzyme stabilization system comprising carboxylic acids for aqueous liquid detergent compositions is disclosed.
SUMMARY OF THE INVENTION
One object of the present invention is to provide a stable liquid composition.
It has surprisingly been found that aryl carboxylic acids have extraordinary good capacities as enzyme stabilizers in liquids, especially of the following formula:
or a salt hereof, wherein R1 is selected from the group consisting of CO, C1 , C2, C3, C4, C5 alkyl, substituted C1 , C2, C3, C4, C5 alkyl, C1 , C2, C3, C4, C5 alkenyl and substituted C1 , C2, C3, C4, C5, alkenyl and R2, R3, R4, R5 and Re is selected from the group consisting of hydrogen, C1 , C2, C3, C4, C5, C6 alkyl, substituted C1 , C2, C3, C4, C5, C6 alkyl, aryl, sub- stituted aryl, hydroxyl, hydroxyl derivative, amine, C1 , C2, C3, C4, C5, C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phosphonate.
The present invention provides thus in a first aspect a liquid composition comprising an enzyme and an enzyme stabilizer of the following formula:
or a salt hereof, wherein R1 is selected from the group consisting of C0-C5 alkyl, substituted C1-C5 alkyl, C1-C5 alkenyl and substituted C1-C6 alkenyl and R2, R3, R4, Rs and R6 is selected from the group consisting of hydrogen, C1-C6 alkyl, substituted C1 to C6 alkyl, aryl, substituted aryl, hydroxyl, hydroxyl derivative, amine, C1-C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phos- phonate.
DETAILED DESCRIPTION OF THE INVENTION
The stabilizer
The present invention relates to stabilization of enzymes in liquid compositions. In a particular embodiment the present invention provides a liquid composition comprising an enzyme and an enzyme stabilizer of the following formula:
or a salt hereof, wherein R1 is selected from the group consisting of C0-C5 alkyl, substituted C1-C5 alkyl, C1-C5 alkenyl and substituted C1-C6 alkenyl. In a particular embodiment R1 is CH2, CH2-CH2, CH2-CH2-CH2 or CH2-CH2-CH2-CH2. In a most particular embodiment R1 is CO, CH2 or CH2-CH2, and R2, R3, R4, R5 and/or R6 is selected from the group consisting of hydrogen, C1 , C2, C3, C4, C5, C6 alkyl, substituted C1 , C2, C3, C4, C5, C6 alkyl, aryl, substituted aryl, hydroxyl, hydroxyl derivative, amine, C1 , C2, C3, C4, C5, C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phosphonate. In one embodiment R2, R3, R4, R5 and/or R6 is selected from the group consisting of hydrogen, C2, C3, C5, C6 alkyl, substituted C2, C3, C5, C6 alkyl, aryl, substituted aryl, hydroxyl, hydroxyl derivative, amine, C1 , C2, C3, C4, C5, C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phosphonate.
In a particular embodiment the R2, R3, R4, R5, R6 is CH3, CH3CH2 and/or CH3CH2CH2. In a particular embodiment the present invention provides a liquid composition comprising an enzyme and an enzyme stabilizer of the formula disclosed above, wherein R2 and R6 are hydrogens.
In another embodiment at least one of the substituents of R2, R3, R4, R5, R6 are selected from the group consisting of C1 to C6 alkyl, substituted C1 to C6 alkyl, aryl, substituted aryl, C1 to C6 alkyl hydroxyl, hydroxyl derivative, amine, C1-C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate and phosphonate.
In a particular embodiment at least one of the substituents of R2, R3, R4, R5, R6 are selected from the group consisting of C2, C3, C5, C6 alkyl, substituted C5, C6 alkyl, aryl, substituted aryl,C2, C3, C5, C6 alkyl hydroxyl, amine, C1-C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate and phosphonate.
In a particular embodiment the stabilizer is selected from the group consisting of benzoic acid, 3-formylbenzoic acid, 4-formylbenzoic acid, 3-nitrobenzoic acid, 4-nitrobenzoic acid, 3,5-dinitrobenzoic acid, 3,4-dinitrobenzoic acid, 3-chlorobenzoic acid, 4-chlorobenzoic acid, 3,5-dichlorobenzoic acid, 3,4-dichlorobenzoic acid, 3-chloromethylbenzoic acid, 4- chloromethyl benzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, 3,5-diaminobenzoic acid, 3,4-diaminobenzoic acid, 3-aminomethylbenzoic acid, 4-aminomethylbenzoic acid, 3- hydroxybenzoic acid, 4-hydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 3,4- dihydroxybenzoic acid, 4-hydroxy-3-methoxybenzoic acid (vanillic acid), phenylacetic acid, 3- chlorophenylacetic acid, 4-chlorophenylacetic acid, 3-nitrophenylacetic acid, 4- nitrophenylacetic acid, 3-aminohenylacetic acid, 4-aminophenylacetic acid, 3-phenylpropionic acid, 2-phenylpropionic acid, S-chlorophenyl-S-propionic acid, 4-chloro-phenyl-3-propionic acid, cinnamic acid and terephthalic acid and their corresponding salts In a particular embodiment of the present invention the stabilizer is not Benzoic acid if the pH of the liquid composition is below 7.
It has further been found that aldehydes of the below formula also are particularly well suited as stabilizers in liquid compositions comprising an enzyme. The aldehydes have the following formula:
or a salt hereof, wherein R1 is selected from the group consisting of C0-C5 alkyl, substituted C1-C5 alkyl, C1-C5 alkenyl and substituted C1-C6 alkenyl. In a particular embodiment R1 is CH2, CH2-CH2, CH2-CH2-CH2 or CH2-CH2-CH2-CH2. In a most particular embodiment R1 is CO, CH2 or CH2-CH2, and R2, R3, R4, R5 and/or R6 is selected from the group consisting of hydrogen, C1 , C2, C3, C4, C5, C6 alkyl, substituted C1 , C2, C3, C4, C5, C6 alkyl, aryl, substituted aryl, hydroxyl, hydroxyl derivative, amine, C1 , C2, C3, C4, C5, C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phosphonate. In a particular embodiment the R2, R3, R4, R5, Re is CH3, CH3CH2 and/or CH3CH2CH2. In a particular embodiment the present invention provides a liquid composition comprising an enzyme and an enzyme stabilizer of the formula disclosed above, wherein R2 and R6 are hydrogens.
In another embodiment at least one of the substituents of R2, R3, R4, R5, R6 are selected from the group consisting of C1 to C6 alkyl, substituted C1 to C6 alkyl, aryl, substituted aryl, C1 to C6 alkyl hydroxyl, hydroxyl derivative, amine, C1-C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate and phosphonate.
In a particular embodiment at least one of the substituents of R2, R3, R4, R5, R6 are selected from the group consisting of C2, C3, C5, C6 alkyl, substituted C5, C6 alkyl, aryl, sub- stituted aryl,C2, C3, C5, C6 alkyl hydroxyl, amine, C1-C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate and phosphonate. In a particular embodiment the stabilizer is selected from the group consisting of Benzalde- hyde, Phenyl acetaldehyde, Phenyl propionaldehyde, 3,5-dichorobenzaldehyde, 4-formyl- benzaldehyde, 4-carboxybenzaldehyde, 3-chlorobenzaldehyde, 4-chlorobenzaldehyde, 3-(3- chlorophenyl)propionaldehyde, 3-chlorophenylacetaldehyde, 3-(4-chlorophenyl)propion- aldehyde, 4-chlorophenylacetaldehyde, 2-chlorophenylacetaldehyde, 2-chlorobenzaldehyde, 2-aminobenzaldehyde, 3-aminobenzaldehyde, 4-aminobenzaldehyde, 3- bromobenzaldehyde, 3-iodobenzaldehyde, 3-nitrobenzaldehyde, 3-fluorobenzaldehyde, 3- formylbenzaldehyde, 3-(chloromethyl)benzaldehyde, 3,5-dihydroxybenzaldehyde, 4- phenylbutyraldehyde.
In a particular embodiment the enzyme stabilizer is substituted in its 3, 4 and/or 5 position. In a more particular embodiment the enzyme stabilizer is substituted in its 4 position i.e. para- substituted. In a most particular embodiment the enzyme stabilizer is substituted in its 3 and/or 5 positions.
In a particular embodiment of the present invention the liquid composition comprises 0.001- 20% w/w of the stabilizer. In a more particular embodiment of the present invention the liquid composition comprises 0.01-15% of the stabilizer. In an even more particular embodiment of the present invention the liquid composition comprises 0.1-10% w/w of the stabilizer. In a most particular embodiment of the present invention the liquid composition comprises 0.5-5 % of the stabilizer. In a further particular embodiment of the present invention the liquid composition comprises 1.5 to 5% w/w of the stabilizer.
In a particular embodiment of the present invention the liquid composition comprises 0.05- 1000 imM of the stabilizer. In a more particular embodiment of the present invention the liquid composition comprises 0.5-750 mM of the stabilizer. In an even more particular embodiment of the present invention the liquid composition comprises 5-500 mM of the stabilizer. In a most particular embodiment of the present invention the liquid composition comprises 25-250 mM of the stabilizer In a particular embodiment the present invention provides a liquid detergent composition comprising a surfactant, an enzyme and an enzyme stabilizer of any of the formulas disclosed above.
It has surprisingly been found that the stabilizer also have a stabilizing effect at pH above 8 such as above 9. Active compounds
According to the invention the liquid composition contains at least one enzyme. The enzyme may be any commercially available enzyme, in particular an enzyme selected from the group consisting of proteases, amylases, lipases, cellulases, lyases, oxidoreductases and any mixture thereof. Mixtures of enzymes from the same class (e.g. proteases) are also included.
In a particular embodiment the liquid composition comprises more than 2 different enzymes. According to the invention a liquid composition comprising a protease is preferred. In a particular embodiment a liquid composition comprising two or more enzymes in which the first enzyme is a protease and the second enzyme is selected from the group consisting of amylases, lipases, cellulases, lyases and oxidoreductases is preferred. In a more particular embodiment the second enzyme is a lipase.
It is to be understood that enzyme variants (produced, for example, by recombinant techniques) are included within the meaning of the term "enzyme". Examples of such enzyme variants are disclosed, e.g. in EP 251 ,446 (Genencor), WO 91/00345 (Novozymes),
EP 525,610 (Solvay) and WO 94/02618 (Gist-Brocades NV).
Enzymes can be classified on the basis of the handbook Enzyme Nomenclature from NC-
IUBMB, 1992), see also the ENZYME site at the internet: ENZYME is a repository of information relative to the nomenclature of enzymes. It is primarily based on the recommendations of the Nomenclature Committee of the International Union of
Biochemistry and Molecular Biology (IUB-MB), Academic Press, Inc., 1992, and it describes each type of characterized enzyme for which an EC (Enzyme Commission) number has been provided (Bairoch A. The ENZYME database, 2000, Nucleic Acids Res 28:304-305). This IUB-MB Enzyme nomenclature is based on their substrate specificity and occasionally on their molecular mechanism; such a classification does not reflect the structural features of these enzymes.
Another classification of certain glycoside hydrolase enzymes, such as endoglucanase, xy- lanase, galactanase, mannanase, dextranase and alpha-galactosidase, in families based on amino acid sequence similarities has been proposed a few years ago. They currently fall into
90 different families: See the CAZy (ModO) internet site (Coutinho, P.M. & Henrissat, B.
(1999) Carbohydrate-Active Enzymes server at URL: jχttj3^/afjττb1cnrj3^^^ (corresponding papers: Coutinho, P.M. &
Henrissat, B. (1999) Carbohydrate-active enzymes: an integrated database approach. In "Recent Advances in Carbohydrate Bioengineering", HJ. Gilbert, G. Davies, B. Henrissat and B. Svensson eds., The Royal Society of Chemistry, Cambridge, pp. 3-12; Coutinho, P.M.
& Henrissat, B. (1999) The modular structure of cellulases and other carbohydrate-active en- zymes: an integrated database approach. In "Genetics, Biochemistry and Ecology of Cellulose Degradation"., K. Ohmiya, K. Hayashi, K. Sakka, Y. Kobayashi, S. Karita and T. Kimura eds., Uni Publishers Co., Tokyo, pp. 15-23).
The liquid composition preferably comprises a protease, such as a serine protease. Proteases: Suitable proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically or genetically modified mutants are included. The protease may be a serine protease, preferably an alkaline microbial protease or a trypsin-like protease. Examples of al-kaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279). Examples of trypsin-like proteases are tryp-sin (e.g. of porcine or bovine origin) and the Fusarium pro-tease described in WO 89/06270. In a particular embodiment of the present invention the protease is a serine protease. Serine proteases or serine endopeptidases (newer name) are a class of peptidases which are characterised by the presence of a serine residue in the active center of the enzyme. Serine proteases: A serine protease is an enzyme which catalyzes the hydrolysis of peptide bonds, and in which there is an essential serine residue at the active site (White, Handler and Smith, 1973 "Principles of Biochemistry," Fifth Edition, McGraw-Hill Book Company, NY, pp. 271-272). The bacterial serine proteases have molecular weights in the 20,000 to 45,000 Daltons range. They are inhibited by diisopropylfluorophosphate. They hydrolyze simple terminal esters and are similar in activity to eukaryotic chymotrypsin, also a serine protease. A more narrow term, alkaline protease, covering a sub group, reflects the high pH optimum of some of the serine proteases, from pH 9.0 to 1 1.0 (for review, see Priest (1977) Bacteriological Rev. 41 71 1-753). Subtilases: A sub-group of the serine proteases tentatively designated subtilases has been proposed by Siezen et al. (1991 ), Protein Eng., 4 719-737. They are defined by homology analysis of more than 40 amino acid sequences of serine proteases previously referred to as subtilisin-like proteases. A subtilisin was previously defined as a serine protease produced by Gram-positive bacteria or fungi, and according to Siezen et al. now is a subgroup of the subtilases. A wide variety of subtilisins have been identified, and the amino acid sequence of a number of subtilisins have been determined. These include more than six subtilisins from Bacillus strains, namely, subtilisin 168, subtilisin BPN', subtilisin Carlsberg, subtilisin Y, subtilisin amylosacchariticus, and mesentericopeptidase (Kurihara et al. (1972) J. Biol. Chem. 247 5629-5631 ; Wells et al. (1983) Nucleic Acids Res. 11 791 1-7925; Stahl and Ferrari (1984) J. Bacteriol. 159 81 1-819, Jacobs et al. (1985) Nucl. Acids Res. 13 8913-8926; Nedkov et al. (1985) Biol. Chem. Hoppe-Seyler 366 421-430, Svendsen et al. (1986) FEBS Lett. 196 228-232), one subtilisin from an actinomycetales, thermitase from Thermoactinomyces vulgaris (Meloun et al. (1985) FEBS Lett. 198 195-200), and one fungal subtilisin, proteinase K from Tritirachium album (Jany and Mayer (1985) Biol.Chem. Hoppe- Seyler 366 584-492). for further reference Table I from Siezen et al. has been reproduced below. Subtilisins are well-characterized physically and chemically. In addition to knowledge of the primary structure (amino acid sequence) of these enzymes, over 50 high resolution X-ray structures of subtilisins have been determined which delineate the binding of substrate, transition state, products, at least three different protease inhibitors, and define the structural consequences for natural variation (Kraut (1977) Ann. Rev. Biochem. 46 331-358). One subgroup of the subtilases, I-S1 , comprises the "classical" subtilisins, such as subtilisin 168, subtilisin BPN', subtilisin Carlsberg (ALCALASE®, Novozymes A/S), and subtilisin DY. A further subgroup of the subtilases I-S2, is recognised by Siezen et al. (supra). Sub-group I- S2 proteases are described as highly alkaline subtilisins and comprise enzymes such as subtilisin PB92 (MAXACAL®, Gist-Brocades NV), subtilisin 309 (SAVINASE®, Novozymes A/S), subtilisin 147 (ESPERASE®, Novozymes A/S), and alkaline elastase YaB.
Random and site-directed mutations of the subtilase gene have both arisen from knowledge of the physical and chemical properties of the enzyme and contributed information relating to subtilase's catalytic activity, substrate specificity, tertiary structure, etc. (Wells et al. (1987) Proc. Natl. Acad. Sci. U.S.A. 84; 1219-1223; Wells et al. (1986) Phil. Trans. R. Soc. Lond.A. 317 415-423; Hwang and Warshel (1987) Biochem. 26 2669-2673; Rao et al., (1987) Nature 328 551-554.
More recent publications covering this area are Carter et al. (1989) Proteins 6 240-248 relating to design of variants that cleave a specific target sequence in a substrate (positions 24 and 64); Graycar et al. (1992) Annals of the New York Academy of Sciences 672 71-79 discussing a number of previously published results; and Takagi (1993) Int. J. Biochem. 25 307-312 also reviewing previous results.
Examples of commercially available proteases (peptidases) include Kannase™, Everlase™, Esperase™, Alcalase™, Neutrase™, Durazym™, Savinase™, Ovozyme™, Pyrase™, Pancreatic Trypsin NOVO (PTN), Bio-Feed™ Pro and Clear-Lens™ Pro (all available from Novozymes A/S, Bagsvaerd, Denmark). Other preferred proteases include those described in WO 01/58275 and WO 01/58276.
Other commercially available proteases include Ronozyme™ Pro, Maxatase™, Maxacal™, Maxapem™, Opticlean™, Propease™, Purafect™ and Purafect Ox™ (available from Genencor International Inc., Gist-Brocades, BASF, or DSM Nutritional Products). Lipases: Suitable lipases include those of bacterial or fungal origin. Chemically or genetically modified mutants are included.
Examples of useful lipases include a Humicola lanugi-nosa lipase, e.g., as described in EP 258 068 and EP 305 216, a Rhizomucor miehei lipase, e.g., as described in EP 238 023, a Candida lipase, such as a C. antarctica lipase, e.g., the C. antarctica lipase A or B described in EP 214 761 , a Pseu-domonas lipase such as a P. pseudoalcaligenes and P. alcali-genes lipase, e.g., as described in EP 218 272, a P. cepacia lipase, e.g., as described in EP 331 376, a P. stutzeri li-pase, e.g., as disclosed in BP 1 ,372,034, a P. fluorescens lipase, a Bacillus lipase, e.g., a B. subtilis lipase (Dar-tois et al., (1993), Biochemica et Biophysica acta 1 131 , 253-260), a B. stearothermophilus lipase (JP 64/744992) and a B. pumilus lipase (WO 91/16422).
Furthermore, a number of cloned lipases may be useful, including the Penicillium camenbertii lipase described by Ya-maguchi et al., (1991 ), Gene 103, 61-67), the Geotricum can-didum lipase (Schimada, Y. et al., (1989), J. Biochem. 106, 383-388), and various Rhizopus lipases such as a R. delemar lipase (Hass, MJ et al., (1991 ), Gene 109, 1 17-1 13), a R. niveus lipase (Kugimiya et al., (1992), Biosci. Biotech. Bio-chem. 56, 716-719) and a R. oryzae lipase.
Other types of lipolytic enzymes such as cutinases may also be useful, e.g., a cutinase derived from Pseudomonas mendocina as described in WO 88/09367, or a cutinase derived from Fusarium solani pisi (e.g. described in WO 90/09446).
Examples of commercially available lipases include Lipex™, Lipoprime™, Lipopan™, Lipolase™, Lipolase™ Ultra, Lipozyme™, Palatase™, Resinase™, Novozym™ 435 and Lecitase™ (all available from Novozymes A/S). Other commercially available lipases include Lumafast™ (Pseudomonas mendocina lipase from Genencor International Inc.); Lipomax™ (Ps. pseudoalcaligenes lipase from Gist- Brocades/Genencor Int. Inc.; and Bacillus sp. lipase from Solvay enzymes. Further lipases are available from other suppliers such as Lipase P "Amano" (Amano Pharmaceutical Co. Ltd.). Amylases: Suitable amylases (α and/or β) include those of bacterial or fungal origin. Chemically or genetically modified mutants are included. Amylases include, for example, a- amylases obtained from a special strain of B. licheniformis, described in more detail in British Patent Specification No. 1 ,296,839. Commercially available amylases are Duramyl™, Termamyl™, Fungamyl™ and BAN™ (available from Novozymes A/S) and Rapidase™ and Maxamyl P™ (available from Gist-Brocades). Cellulases: Suitable cellulases include those of bacterial or fungal origin. Chemically or genetically modified mu-tants are included. Suitable cellulases are disclosed in US 4,435,307, which discloses fungal cellulases produced from Humicola insolens. Especially suitable cellulases are the cellulases having color care benefits. Examples of such cellulases are cellulases described in European patent application No. 0 495 257. Oxidoreductases: Any oxidoreductase suitable for use in a liquid composition, e.g., peroxidases or oxidases such as laccases, can be used herein. Suitable peroxidases herein include those of plant, bacterial or fungal origin. Chemically or genetically modified mutants are included. Examples of suitable peroxidases are those derived from a strain of Coprinus, e.g., C. cinerius or C. macrorhizus, or from a strain of Bacillus, e.g., B. pumilus, particularly peroxidase according to WO 91/05858. Suitable laccases herein include those of bacterial or fungal origin. Chemically or genetically modified mutants are included. Examples of suitable laccases are those obtainable from a strain of Trametes, e.g., T. villosa or T. versicolor, or from a strain of Coprinus, e.g., C. cinereus, or from a strain of Myceliophthora, e.g., M. thermophila.
The types of enzymes which may be present in the liquid of the invention include oxidoreductases (EC 1.-.-.-), transferases (EC 2.-.-.-), hydrolases (EC 3.-.-.-), lyases (EC 4.-.- .-), isomerases (EC 5.-.-.-) and ligases (EC 6.-.-.-).
Preferred oxidoreductases in the context of the invention are peroxidases (EC 1.11.1 ), laccases (EC 1.10.3.2) and glucose oxidases (EC 1.1.3.4)]. An Example of a commercially available oxidoreductase (EC 1.-.-.-) is Gluzyme™ (enzyme available from Novozymes A/S). Further oxidoreductases are available from other suppliers. Preferred transferases are transferases in any of the following sub-classes: a Transferases transferring one-carbon groups (EC 2.1 ); b transferases transferring aldehyde or ketone residues (EC 2.2); acyltransferases (EC
2.3); c glycosyltransferases (EC 2.4); d transferases transferring alkyl or aryl groups, other that methyl groups (EC 2.5); and e transferases transferring nitrogeneous groups (EC 2.6).
A most preferred type of transferase in the context of the invention is a transglutaminase (protein-glutamine γ-glutamyltransferase; EC 2.3.2.13). Further examples of suitable transglutaminases are described in WO 96/06931 (Novozymes A/S).
Preferred hydrolases in the context of the invention are: carboxylic ester hydrolases (EC 3.1.1.-) such as lipases (EC 3.1.1.3); phytases (EC 3.1.3.-), e.g. 3-phytases (EC 3.1.3.8) and 6-phytases (EC 3.1.3.26); glycosidases (EC 3.2, which fall within a group denoted herein as "carbohydrases"), such as α-amylases (EC 3.2.1.1 ); peptidases (EC 3.4, also known as proteases); and other carbonyl hydrolases. Examples of commercially available phytases include Bio-Feed™ Phytase (Novozymes), Ronozyme™ P (DSM Nutritional Products), Natuphos™ (BASF), Finase™ (AB Enzymes), and the Phyzyme™ product series (Danisco). Other preferred phytases include those described in WO 98/28408, WO 00/43503, and WO 03/066847.
In the present context, the term "carbohydrase" is used to denote not only enzymes capable of breaking down carbohydrate chains (e.g. starches or cellulose) of especially five- and six- membered ring structures (i.e. glycosidases, EC 3.2), but also enzymes capable of isomerizing carbohydrates, e.g. six-membered ring structures such as D-glucose to five- membered ring structures such as D-fructose.
Carbohydrases of relevance include the following (EC numbers in parentheses): α-amylases (EC 3.2.1.1 ), β-amylases (EC 3.2.1.2), glucan 1 ,4-α-glucosidases (EC 3.2.1.3), endo-1 ,4-beta-glucanase (cellulases, EC 3.2.1.4), endo-1 ,3(4)-β-glucanases (EC 3.2.1.6), endo-1 ,4-β-xylanases (EC 3.2.1.8), dextranases (EC 3.2.1.11 ), chitinases (EC 3.2.1.14), polygalacturonases (EC 3.2.1.15), lysozymes (EC 3.2.1.17), β-glucosidases (EC 3.2.1.21 ), α- galactosidases (EC 3.2.1.22), β-galactosidases (EC 3.2.1.23), amylo-1 ,6-glucosidases (EC 3.2.1.33), xylan 1 ,4-β-xylosidases (EC 3.2.1.37), glucan endo-1 ,3-β-D-glucosidases (EC 3.2.1.39), α-dextrin endo-1 ,6-α-glucosidases (EC3.2.1.41 ), sucrose α-glucosidases (EC 3.2.1.48), glucan endo-1 ,3-α-glucosidases (EC 3.2.1.59), glucan 1 ,4-β-glucosidases (EC 3.2.1.74), glucan endo-1 ,6-β-glucosidases (EC 3.2.1.75), galactanases (EC 3.2.1.89), arabi- nan endo-1 ,5-α-L-arabinosidases (EC 3.2.1.99), lactases (EC 3.2.1.108), chitosanases (EC 3.2.1.132) and xylose isomerases (EC 5.3.1.5).
Examples of commercially available carbohydrases include Alpha-Gal™, Bio-Feed™ Alpha, Bio-Feed™ Beta, Bio-Feed™ Plus, Bio-Feed™ Wheat, Bio-Feed™ Z, Novozyme™ 188, Carezyme™, Celluclast™, Cellusoft™, Celluzyme™, Ceremyl™, Citrozym™, Denimax™, Dezyme™, Dextrozyme™, Duramyl™, Energex™, Finizym™, Fungamyl™, Gamanase™, Glucanex™, Lactozym™, Liquezyme™, Maltogenase™, Natalase™, Pentopan™, Pectinex™, Promozyme™, Pulpzyme™, Novamyl™, Termamyl™, AMG™ (Amyloglucosidase Novo), Maltogenase™, Sweetzyme™ and Aquazym™ (all available from Novozymes A/S). Further carbohydrases are available from other suppliers, such as the Roxazyme™ and Ronozyme™ product series (DSM Nutritional Products), the Avizyme™, Porzyme™ and Grindazyme™ product series (Danisco, Finnfeeds), and Natugrain™ (BASF) , Purastar™ and Purastar™ OxAm (Genencor).
Other commercially available enzymes include Mannaway™, Pectaway™, Stainzyme™ and Renozyme™. The Composition
The composition may be any composition, but particularly suitable compositions are cleaning compositions, personal care compositions, textile processing compositions e.g. bleaching, pharmaceutical compositions, leather processing compositions, pulp or paper processing compositions, food and beverage compositions and animal feed compositions.
In a particular embodiment of the present invention the liquid composition is a liquid detergent, e.g. laundry detergent or dishwashing detergent. In a more particular embodiment of the present invention the composition comprises a surfactant. The invention is further directed to the use of the liquid enzyme additive in liquid detergent composition.
The liquid composition may be a concentrated product to be added to liquid detergents. The amount of enzyme used in the liquid composition is thus very high. In a particular embodiment of the present invention the amount of enzyme present in the liquid composition is at least 1.5 g/L. In a more particular embodiment of the present invention the amount of enzyme is at least 5 g/L. In an even more particular embodiment of the present invention the amount of enzyme present is at least 10 g/L. In a most particular embodiment of the present invention the amount of enzyme present is at least 20 g/L such as even above 25 g/L. In a particular embodiment the amount of enzyme does not exceed 200 g/L. In a more particular embodiment of the present invention the amount of enzyme does not exceed 150 g/L. In a most particular embodiment of the present invention the amount of enzyme present in the liquid composition is less than 100 g/L.
In a particular embodiment of the present invention the liquid composition has a pH of more than 7.5. In a more particular embodiment the pH of the liquid composition is at least 7.7. In a most particular embodiment the pH of the liquid composition is at least 8.0. In a most particular embodiment of the present invention the liquid composition contain one or more detergent builders. In a particular embodiment of the present invention the liquid composition comprises at least 1 % w/w of detergent builders. In a more particular embodiment of the present invention the liquid composition comprises at least 2% w/w of detergent builders. In a most particular embodiment of the present invention the liquid composition comprises at least 5% w/w of detergent builders.
The present invention is further described by the following examples which should not be construed as limiting the scope of the invention. Detergent compositions
In a particular embodiment of the present invention the liquid composition is a liquid detergent composition. In a more particular embodiment of the present invention the liquid composition is a liquid detergent composition for dishwashing or for laundry. The enzyme of the invention may be added to and thus become a component of a detergent composition.
The detergent composition of the invention may for example be formulated as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre- treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
The detergent composition may comprise one or more enzymes such as a protease, a lipase, a cutinase, an amylase, a carbohydrase, a cellulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase, an oxidase, e.g., a laccase, and/or a peroxidase. In general the properties of the chosen enzyme(s) should be compatible with the selected detergent, (i.e. pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.
Proteases: Suitable proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included. The protease may be a serine protease or a metallo protease, preferably an alkaline microbial protease or a trypsin-like protease. Examples of alkaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279). Examples of trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in WO 89/06270 and WO 94/25583.
Examples of useful proteases are the variants described in WO 92/19729, WO 98/201 15, WO 98/20116, and WO 98/34946.
Preferred commercially available protease enzymes include Alcalase™, Savinase™, Primase™, Duralase™, Esperase™, and Kannase™ (Novozymes A/S), Maxatase™, Maxacal™, Maxapem™, Properase™, Purafect™, Purafect OxP™, FN2™, and FN3™ (Genencor International Inc.).
Lipases: Suitable lipases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful lipases include lipases from Humicola (synonym Thermomyces), e.g. from H. lanuginosa (T. lanuginosus) as described in EP 258 068 and EP 305 216 or from H. insolens as described in WO 96/13580, a Pseudomonas lipase, e.g. from P. alcaligenes or P. pseudoalcaligenes (EP 218 272), P. cepacia (EP 331 376), P. stutzeri (GB 1 ,372,034), P. fluorescens, Pseudomonas sp. strain SD 705 (WO 95/06720 and WO 96/27002), P. wisconsinensis (WO 96/12012), a Bacillus lipase, e.g. from B. subtilis (Dartois et al. (1993), Biochemica et Biophysica Acta, 1 131 , 253-
360), B. stearothermophilus (JP 64/744992) or B. pumilus (WO 91/16422).
Other examples are lipase variants such as those described in WO 92/05249, WO 94/01541 , EP 407 225, EP 260 105, WO 95/35381 , WO 96/00292, WO 95/30744, WO 94/25578, WO
95/14783, WO 95/22615, WO 97/04079 and WO 97/07202.
Preferred commercially available lipase enzymes include Lipolase™ and Lipolase Ultra™
(Novozymes A/S).
Amylases: Suitable amylases (α and/or β) include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, α-amylases obtained from Bacillus, e.g. a special strain of B. licheniformis, described in more detail in GB 1 ,296,839.
Examples of useful amylases are the variants described in WO 94/02597, WO 94/18314,
WO 96/23873, and WO 97/43424. Commercially available amylases are Duramyl™, Termamyl™, Fungamyl™ and BAN™
(Novozymes A/S), Rapidase™ and Purastar™ (from Genencor International Inc.).
Cellulases: Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g. the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4,435,307, US 5,648,263, US 5,691 ,178, US 5,776,757 and WO
89/09259.
Especially suitable cellulases are the alkaline or neutral cellulases having colour care benefits. Examples of such cellulases are cellulases described in EP 0 495 257, EP 0 531 372, WO 96/1 1262, WO 96/29397, WO 98/08940. Other examples are cellulase variants such as those described in WO 94/07998, EP 0 531 315, US 5,457,046, US 5,686,593, US
5,763,254, WO 95/24471 , WO 98/12307 and PCT/DK98/00299.
Commercially available cellulases include Celluzyme™, and Carezyme™ (Novozymes A/S),
Clazinase™, and Puradax HA™ (Genencor International Inc.), and KAC-500(B)™ (Kao Corporation).
Peroxidases/Oxidases: Suitable peroxidases/oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g. from C. cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257. Commercially available peroxidases include Guardzyme™ (Novozymes A/S). The detergent enzyme(s) may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising all of these enzymes.
A liquid detergent may be aqueous, typically containing up to 70 % water and 0-30 % organic solvent, or non-aqueous.
The detergent composition comprises one or more surfactants, which may be non-ionic including semi-polar and/or anionic and/or cationic and/or zwitterionic. The surfactants are typically present at a level of from 0.1 % to 60% by weight. When included therein the detergent will usually contain from about 1 % to about 40% of an ani- onic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
When included therein the detergent will usually contain from about 0.2% to about 40% of a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, al- kyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine ("glucamides"). The detergent may contain 0-65 % of a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylenediami- netetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble sili- cates or layered silicates (e.g. SKS-6 from Hoechst).
The detergent may comprise one or more polymers. Examples are carboxymethylcellulose, poly(vinylpyrrolidone), poly (ethylene glycol), polyvinyl alcohol), poly(vinylpyridine-N-oxide), poly(vinylimidazole), polycarboxylates such as polyacrylates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers. The detergent may contain a bleaching system which may comprise a H2O2 source such as perborate or percarbonate which may be combined with a peracid-forming bleach activator such as tetraacetylethylenediamine or nonanoyloxybenzenesulfonate. Alternatively, the bleaching system may comprise peroxyacids of e.g. the amide, imide, or sulfone type. The enzyme(s) of the detergent composition of the invention may be stabilized using conven- tional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar, sugar alcohol or lactic acid.
In a particular embodiment of the present invention the liquid composition comprises less than 30 % w/v of polyol, such as less than 25% w/v of polyol or even less than 20% w/v of polyol. The detergent may also contain other conventional detergent ingredients such as e.g. fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil- suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydro- tropes, tarnish inhibitors, or perfumes. EXAMPLES
Example 1
The inhibition constant K1 = [E][I]/[EI] for the inhibition of Savinase was determined using standard methods under the following conditions: Substrate: Succinyl-Alanine-Alanine-Proline-para-nitro-anilide = SAAPFpNA (Sigma S- 7388).
Buffer: 0.1 M phosphate buffer pH 7.5 Temperature: 25°C
Enzyme concentration in assay ~ 1 x 10"8 M The initial rate of substrate hydrolysis was determined with and without inhibitor at nine substrate concentrations in the range of 0.01 mM to 2 mM using an automated spectrophotometer. The inhibition constant K, was determined using Sigma Plot 9.0, Enzyme Kinetics Module 1.1
Example 2
The inhibition constant K, = [E][I]/[EI] for the inhibition of Savinase was determined using standard methods under the following conditions:
Substrate: Succinyl-Alanine-Alanine-Proline-para-nitro-anilide = SAAPFpNA (Sigma S- 7388).
Buffer: 0.1 M phosphate buffer pH 7.5
Temperature: 25°C
Enzyme concentration in assay ~ 1 x 10"8 M
The initial rate of substrate hydrolysis was determined with and without inhibitor at nine sub- strate concentrations in the range of 0.01 mM to 2 mM using an automated spectrophotometer. The inhibition constant K, was determined using Sigma Plot 9.0, Enzyme Kinetics Module 1.1
Acids:
Example 3
The inhibition constant K1 = [E][I]/[EI] for the inhibition of Savinase was determined using standard methods under the following conditions: Substrate: Succinyl-Alanine-Alanine-Proline-para-nitro-anilide = SAAPFpNA (Sigma S- 7388).
Buffer: 0.1 M phosphate buffer pH 7.5 Temperature: 25°C Enzyme concentration in assay ~ 1 x 10"8 M
The initial rate of substrate hydrolysis was determined with and without inhibitor at nine substrate concentrations in the range of 0.01 mM to 2 mM using an automated spectrophotometer.
The inhibition constant K1 was determined using Sigma Plot 9.0, Enzyme Kinetics Module 1.1
Aldehydes tested:

Claims

1. A liquid composition comprising an enzyme and an enzyme stabilizer of the following formula:
or a salt hereof, wherein R1 is selected from the group consisting of C0-C5 alkyl, substituted C1-C5 alkyl, C1-C5 alkenyl and substituted C1-C6 alkenyl and R2, R3, R4, R5 and R6 is selected from the group consisting of hydrogen, C1-C6 alkyl, substi- tuted C1 to C6 alkyl, aryl, substituted aryl, hydroxyl, hydroxyl derivative, amine, C1-
C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phosphonate.
2. A liquid composition according to claim 1 , wherein R1 is C0-C5 alkyl.
3. A liquid composition according to claim 1 , wherein the enzyme stabilizer is substituted in position 3, 4, and/or 5.
4. A liquid composition according to claim 1 , wherein the R2 and R6 are hydrogens.
5. A liquid composition according to any of claims 1-4, wherein the enzyme is a protease.
6. A liquid composition according to claim 1 , additionally comprising a second enzyme, in particular an amylase, a lipase, a cellulase or an oxidoreductase, or any mixture thereof.
7. A liquid composition according to any of claims 1-6, wherein said enzyme stabilizer is selected from the group consisting of benzoic acid, 3-formyl benzoic acid, 4- formylbenzoic acid, 3-nitrobenzoic acid, 4-nitrobenzoic acid, 3,5-dinitrobenzoic acid, 3,4-dinitrobenzoic acid, 3-chlorobenzoic acid, 4-chlorobenzoic acid, 3,5- dichlorobenzoic acid, 3,4-dichlorobenzoic acid, 3-chloromethylbenzoic acid, 4- chloromethyl benzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, 3,5- diaminobenzoic acid, 3,4-diaminobenzoic acid, 3-aminomethylbenzoic acid, 4- aminomethylbenzoic acid, 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, 3,5- dihydroxybenzoic acid, 3,4-dihydroxybenzoic acid, 4-hydroxy-3-methoxybenzoic acid (vanillic acid), phenylacetic acid, 3-chlorophenylacetic acid, 4-chlorophenylacetic acid, 3-nitrophenylacetic acid, 4-nitrophenylacetic acid, 3-aminohenylacetic acid, 4- aminophenylacetic acid, 3-phenylpropionic acid, 2-phenylpropionic acid, 3- chlorophenyl-3-propionic acid, 4-chloro-phenyl-3-propionic acid, cinnamic acid and terephthalic acid and their corresponding salts.
8. A liquid composition according to any of claims 1-7, wherein said stabilizer is 0.001-20% w/w of the liquid composition.
9. A liquid detergent composition comprising a surfactant, an enzyme and an enzyme stabilizer of the following formula:
or a salt hereof, wherein R1 is selected from the group consisting of C0-C5 alkyl, substituted C1-C5 alkyl, C1-C5 alkenyl and substituted C1-C6 alkenyl and R2, R3, R4, R5 and Re is selected from the group consisting of hydrogen, C1-C6 alkyl, substituted C1 to C6 alkyl, aryl, substituted aryl, hydroxyl, hydroxyl derivative, amine, C1- C6 alkylated amine, amine derivative, halogen, nitro, thiol, thiol derivative, aldehyde, acid, acid salt, ester, sulfonate or phosphonate.
10. A liquid detergent composition according to claim 9, wherein R1 is C0-C5 alkyl.
11. A liquid detergent composition according to claim 9, wherein the enzyme stabilizer is substituted in position 3, 4, and/or 5.
12. A liquid detergent composition according to claim 9, wherein the R2 and Re are hydrogens.
13. A liquid detergent composition according to any of claims 9-12, wherein the enzyme is a protease.
14. A liquid detergent composition according to claim 9, additionally comprising a second detergent-compatible enzyme, in particular an amylase, a lipase, a cellulase or an oxidoreductase, or any mixture thereof.
15. A liquid detergent composition according to any of claims 9-14, wherein said enzyme stabilizer is selected from the group consisting of benzoic acid, 3-formylbenzoic acid,
4-formylbenzoic acid, 3-nitrobenzoic acid, 4-nitrobenzoic acid, 3,5-dinitrobenzoic acid, 3,4-dinitrobenzoic acid, 3-chlorobenzoic acid, 4-chlorobenzoic acid, 3,5- dichlorobenzoic acid, 3,4-dichlorobenzoic acid, 3-chloromethylbenzoic acid, 4- chloromethyl benzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, 3,5- diaminobenzoic acid, 3,4-diaminobenzoic acid, 3-aminomethylbenzoic acid, 4- aminomethylbenzoic acid, 3-hydroxybenzoic acid, 4-hydroxybenzoic acid, 3,5- dihydroxybenzoic acid, 3,4-dihydroxybenzoic acid, 4-hydroxy-3-methoxybenzoic acid, phenylacetic acid, 3-chlorophenylacetic acid, 4-chlorophenylacetic acid, 3- nitrophenylacetic acid, 4-nitrophenylacetic acid, 3-aminohenylacetic acid, 4- aminophenylacetic acid, 3-phenylpropionic acid, 2-phenylpropionic acid, 3- chlorophenyl-3-propionic acid, 4-chloro-phenyl-3-propionic acid, cinnamic acid and terephthalic acid and their corresponding salts.
16. A liquid detergent composition according to any of claims 9-15, wherein said stabilizer is 0.001-20% w/w of the liquid composition.
EP07727559A 2006-03-31 2007-03-30 A stabilized liquid enzyme composition Not-in-force EP2004789B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP20110175251 EP2383330A1 (en) 2006-03-31 2007-03-30 A stabilized liquid enzyme composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200600460 2006-03-31
PCT/EP2007/053087 WO2007113241A1 (en) 2006-03-31 2007-03-30 A stabilized liquid enzyme composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP20110175251 Division-Into EP2383330A1 (en) 2006-03-31 2007-03-30 A stabilized liquid enzyme composition

Publications (2)

Publication Number Publication Date
EP2004789A1 true EP2004789A1 (en) 2008-12-24
EP2004789B1 EP2004789B1 (en) 2012-08-29

Family

ID=38121266

Family Applications (2)

Application Number Title Priority Date Filing Date
EP07727559A Not-in-force EP2004789B1 (en) 2006-03-31 2007-03-30 A stabilized liquid enzyme composition
EP20110175251 Ceased EP2383330A1 (en) 2006-03-31 2007-03-30 A stabilized liquid enzyme composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP20110175251 Ceased EP2383330A1 (en) 2006-03-31 2007-03-30 A stabilized liquid enzyme composition

Country Status (2)

Country Link
EP (2) EP2004789B1 (en)
WO (1) WO2007113241A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007011236A1 (en) 2007-03-06 2008-09-11 Henkel Ag & Co. Kgaa Carboxyl-bearing benzophenone or benzoic acid anilide derivatives as enzyme stabilizers
DE102007057583A1 (en) 2007-11-28 2009-06-04 Henkel Ag & Co. Kgaa Detergents with stabilized enzymes
US20090209447A1 (en) 2008-02-15 2009-08-20 Michelle Meek Cleaning compositions
BR112012000531A2 (en) 2009-07-09 2019-09-24 Procter & Gamble catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte
WO2011005730A1 (en) 2009-07-09 2011-01-13 The Procter & Gamble Company A catalytic laundry detergent composition comprising relatively low levels of water-soluble electrolyte
DE102009045064A1 (en) 2009-09-28 2011-03-31 Henkel Ag & Co. Kgaa Stabilized enzymatic composition
US8222197B2 (en) 2010-03-12 2012-07-17 The Procter & Gamble Company Liquid detergent compositions comprising pH tuneable amido-gellants, and processes for making
MX2012010572A (en) 2010-03-12 2012-10-09 Procter & Gamble Di-amido gellant for use in consumer product compositions.
DE102010038501A1 (en) 2010-07-27 2012-02-02 Henkel Ag & Co. Kgaa Stabilized liquid enzyme-containing surfactant preparation
DE102010038497A1 (en) 2010-07-27 2012-02-02 Henkel Ag & Co. Kgaa Stabilized liquid enzyme-containing surfactant preparation
DE102010038499A1 (en) 2010-07-27 2012-02-02 Henkel Ag & Co. Kgaa Stabilized liquid enzyme-containing surfactant preparation
DE102010038502A1 (en) 2010-07-27 2012-02-02 Henkel Ag & Co. Kgaa Stabilized liquid enzyme-containing surfactant preparation
DE102010038496A1 (en) 2010-07-27 2012-02-02 Henkel Ag & Co. Kgaa Stabilized liquid enzyme-containing surfactant preparation
DE102010038498A1 (en) 2010-07-27 2012-02-02 Henkel Ag & Co. Kgaa Stabilized liquid enzyme-containing surfactant preparation
DE102010043934A1 (en) 2010-11-15 2012-05-16 Henkel Ag & Co. Kgaa Stabilized liquid enzyme-containing surfactant preparation
US20130303427A1 (en) 2011-09-13 2013-11-14 Susana Fernandez Prieto MICROCAPSULE COMPOSITIONS COMPRISING pH TUNEABLE DI-AMIDO GELLANTS
ES2529502T3 (en) 2011-09-13 2015-02-20 The Procter & Gamble Company Water-stable unit dose stable items
DE102012206571A1 (en) 2012-04-20 2013-10-24 Henkel Ag & Co. Kgaa Storage-stable washing or cleaning agent with increased cleaning performance
DE102014208507A1 (en) 2014-05-07 2015-11-12 Henkel Ag & Co. Kgaa laundry detergent
EP3540052B1 (en) 2018-03-14 2025-11-05 Indian Oil Corporation Limited A stable lignocellulolytic enzyme composition
WO2023288294A1 (en) 2021-07-16 2023-01-19 Novozymes A/S Compositions and methods for improving the rainfastness of proteins on plant surfaces
EP4525615A2 (en) 2022-05-14 2025-03-26 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
WO2025217017A1 (en) 2024-04-08 2025-10-16 Novozymes A/S Compositions and methods for increasing phosphorous availability

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293143A (en) * 1964-08-10 1966-12-20 Castle & Cooke Stabilization of bromelain preparations
GB1296839A (en) 1969-05-29 1972-11-22
GB1372034A (en) 1970-12-31 1974-10-30 Unilever Ltd Detergent compositions
DK187280A (en) 1980-04-30 1981-10-31 Novo Industri As RUIT REDUCING AGENT FOR A COMPLETE LAUNDRY
US4717662A (en) * 1985-01-31 1988-01-05 Miles Laboratories, Inc. Thermal stabilization of alpha-amylase
DK154572C (en) 1985-08-07 1989-04-24 Novo Industri As ENZYMATIC DETERGENT ADDITIVE, DETERGENT AND METHOD FOR WASHING TEXTILES
JPH0697997B2 (en) 1985-08-09 1994-12-07 ギスト ブロカデス ナ−ムロ−ゼ フエンノ−トチヤツプ New enzymatic detergent additive
DK122686D0 (en) 1986-03-17 1986-03-17 Novo Industri As PREPARATION OF PROTEINS
IE65767B1 (en) 1986-04-30 1995-11-15 Genencor Int Non-human carbonyl hydrolase mutants DNA sequences and vectors encoding same and hosts transformed with said vectors
DE3750450T2 (en) 1986-08-29 1995-01-05 Novo Industri As Enzyme-based detergent additive.
NZ221627A (en) 1986-09-09 1993-04-28 Genencor Inc Preparation of enzymes, modifications, catalytic triads to alter ratios or transesterification/hydrolysis ratios
DE3851875T2 (en) 1987-05-29 1995-04-13 Genencor Int CUTINASE CONTAINING DETERGENT COMPOSITIONS.
EP0305216B1 (en) 1987-08-28 1995-08-02 Novo Nordisk A/S Recombinant Humicola lipase and process for the production of recombinant humicola lipases
JPS6474992A (en) 1987-09-16 1989-03-20 Fuji Oil Co Ltd Dna sequence, plasmid and production of lipase
DE68924654T2 (en) 1988-01-07 1996-04-04 Novonordisk As Specific protease.
DK6488D0 (en) 1988-01-07 1988-01-07 Novo Industri As ENZYMES
JP3079276B2 (en) 1988-02-28 2000-08-21 天野製薬株式会社 Recombinant DNA, Pseudomonas sp. Containing the same, and method for producing lipase using the same
US5648263A (en) 1988-03-24 1997-07-15 Novo Nordisk A/S Methods for reducing the harshness of a cotton-containing fabric
JP2728531B2 (en) 1988-03-24 1998-03-18 ノボ ノルディスク アクティーゼルスカブ Cellulase preparation
JP2727112B2 (en) * 1988-04-26 1998-03-11 コニカ株式会社 Stable peroxidase composition and stable antibody composition
AU618808B2 (en) * 1988-05-16 1992-01-09 Protech Incorporated Stabilizer composition and stabilized aqueous systems
DD290778A7 (en) * 1988-12-16 1991-06-13 Martin-Luther-Universitaet Halle Witttenberg,De METHOD FOR INCREASING THE STABILITY OF BIOCATALYZERS
GB8900496D0 (en) * 1989-01-10 1989-03-08 Procter & Gamble Liquid detergent composition containing enzyme and enzyme stabilization system
NL8900267A (en) * 1989-02-03 1990-09-03 Douwe Egberts Tabaksfab LIQUID CLEANER.
WO1990009446A1 (en) 1989-02-17 1990-08-23 Plant Genetic Systems N.V. Cutinase
DK316989D0 (en) 1989-06-26 1989-06-26 Novo Nordisk As ENZYMES
GB8915658D0 (en) 1989-07-07 1989-08-23 Unilever Plc Enzymes,their production and use
PE14291A1 (en) 1989-10-13 1991-04-27 Novo Nordisk As PROCEDURE TO INHIBIT THE TRANSFER OF DYES
KR100236540B1 (en) 1990-04-14 2000-01-15 레클로우크스 라우에르 Alkaline bacillus lipases, coding dna sequences thereof and bacilli which produce these lipases
DK115890D0 (en) 1990-05-09 1990-05-09 Novo Nordisk As ENZYME
DK0531372T4 (en) 1990-05-09 2004-08-09 Novozymes As Cellulase preparation comprising an endoglucanase enzyme
AU657278B2 (en) 1990-09-13 1995-03-09 Novo Nordisk A/S Lipase variants
ES2174820T3 (en) 1991-01-16 2002-11-16 Procter & Gamble COMPOSITIONS OF COMPACT DETERGENTS WITH HIGH ACTIVITY CELL.
DE69206795T2 (en) 1991-04-30 1996-09-05 Procter & Gamble LIQUID DETERGENT CONTAINING ARYLBORONIC ACID
ES2121014T3 (en) 1991-05-01 1998-11-16 Novo Nordisk As STABILIZED ENZYMES AND DETERGENT COMPOSITIONS.
EP0525610A3 (en) 1991-07-27 1993-03-24 Solvay Enzymes Gmbh & Co. Kg Process for increasing the stability of enzymes and stabilized enzymes
DK72992D0 (en) 1992-06-01 1992-06-01 Novo Nordisk As ENZYME
DK88892D0 (en) 1992-07-06 1992-07-06 Novo Nordisk As CONNECTION
KR950702633A (en) 1992-07-17 1995-07-29 한스 발터 라벤 HIGH ALKALINE SERINE PROTEASES
WO1994002597A1 (en) 1992-07-23 1994-02-03 Novo Nordisk A/S MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT
ATE262035T1 (en) 1992-10-06 2004-04-15 Novozymes As CELLULOSE VARIANTS
PT867504E (en) 1993-02-11 2003-08-29 Genencor Int ALPHA-AMYLASE ESTABLISHING OXIDACAO
KR950702240A (en) 1993-04-27 1995-06-19 한스 발터 라벤 New lipase variant for use as a detergent
DK52393D0 (en) 1993-05-05 1993-05-05 Novo Nordisk As
JP2859520B2 (en) 1993-08-30 1999-02-17 ノボ ノルディスク アクティーゼルスカブ Lipase, microorganism producing the same, method for producing lipase, and detergent composition containing lipase
US5817495A (en) 1993-10-13 1998-10-06 Novo Nordisk A/S H2 O2 -stable peroxidase variants
JPH07143883A (en) 1993-11-24 1995-06-06 Showa Denko Kk Lipase gene and mutant lipase
DE69527835T2 (en) 1994-02-22 2003-04-10 Novozymes A/S, Bagsvaerd METHOD FOR PRODUCING A VARIANT OF A LIPOLYTIC ENZYME
DE69536145D1 (en) 1994-03-08 2011-04-07 Novozymes As Novel alkaline cellulases
WO1995030744A2 (en) 1994-05-04 1995-11-16 Genencor International Inc. Lipases with improved surfactant resistance
WO1995035381A1 (en) 1994-06-20 1995-12-28 Unilever N.V. Modified pseudomonas lipases and their use
AU2884695A (en) 1994-06-23 1996-01-19 Unilever Plc Modified pseudomonas lipases and their use
NZ291414A (en) 1994-08-26 1998-05-27 Novo Nordisk As Microbial transglutaminases and methods of production using fungi and dna constructs
DE69535733T2 (en) 1994-10-06 2009-04-23 Novozymes A/S An enzymatic with endoglucanase activity
BE1008998A3 (en) 1994-10-14 1996-10-01 Solvay Lipase, microorganism producing the preparation process for the lipase and uses thereof.
US5827719A (en) 1994-10-26 1998-10-27 Novo Nordisk A/S Enzyme with lipolytic activity
AR000862A1 (en) 1995-02-03 1997-08-06 Novozymes As VARIANTS OF A MOTHER-AMYLASE, A METHOD TO PRODUCE THE SAME, A DNA STRUCTURE AND A VECTOR OF EXPRESSION, A CELL TRANSFORMED BY SUCH A DNA STRUCTURE AND VECTOR, A DETERGENT ADDITIVE, DETERGENT COMPOSITION, A COMPOSITION FOR AND A COMPOSITION FOR THE ELIMINATION OF
JPH08228778A (en) 1995-02-27 1996-09-10 Showa Denko Kk Novel lipase gene and method for producing lipase using the same
CN102080070B (en) 1995-03-17 2016-01-20 诺沃奇梅兹有限公司 new endoglucanase
US6184189B1 (en) * 1995-06-07 2001-02-06 Alcon Laboratories, Inc. Liquid enzyme compositions and methods of use in contact lens cleaning and disinfecting systems
DE69621131T2 (en) 1995-06-13 2002-11-28 Novozymes A/S, Bagsvaerd 4-SUBSTITUTED-PHENYLBORONIC ACIDS AS ENZYME STABILIZERS
EP0839186B1 (en) 1995-07-14 2004-11-10 Novozymes A/S A modified enzyme with lipolytic activity
AU6655196A (en) 1995-08-11 1997-03-12 Novo Nordisk A/S Novel lipolytic enzymes
US5672213A (en) * 1995-08-18 1997-09-30 Alcon Laboratories, Inc. Liquid enzyme compositions containing aromatic acid derivatives
US5763385A (en) 1996-05-14 1998-06-09 Genencor International, Inc. Modified α-amylases having altered calcium binding properties
AU3938997A (en) 1996-08-26 1998-03-19 Novo Nordisk A/S A novel endoglucanase
EP1726644A1 (en) 1996-09-17 2006-11-29 Novozymes A/S Cellulase variants
WO1998015257A1 (en) 1996-10-08 1998-04-16 Novo Nordisk A/S Diaminobenzoic acid derivatives as dye precursors
EP0932667B1 (en) 1996-11-04 2008-10-01 Novozymes A/S Subtilase variants and compositions
JP4044143B2 (en) 1996-11-04 2008-02-06 ノボザイムス アクティーゼルスカブ Subtilase variants and compositions
WO1998022567A1 (en) * 1996-11-18 1998-05-28 Alcon Laboratories, Inc. Stable liquid enzyme compositions for cleaning contact lenses
JP3504672B2 (en) 1996-12-20 2004-03-08 ノボザイムス アクティーゼルスカブ Peniophora phytase
WO1998034946A1 (en) 1997-02-12 1998-08-13 Massachusetts Institute Of Technology Daxx, a novel fas-binding protein that activates jnk and apoptosis
ATE338110T1 (en) 1999-01-22 2006-09-15 Novozymes As IMPROVED PHYTASES
CA2395266C (en) 2000-02-08 2009-04-14 F. Hoffmann-La Roche Ag Use of acid-stable subtilisin proteases in animal feed
US6813003B2 (en) 2002-06-11 2004-11-02 Mark Oskotsky Advanced illumination system for use in microlithography
JP4426307B2 (en) 2002-02-08 2010-03-03 ノボザイムス アクティーゼルスカブ Phytase mutant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2007113241A1 *

Also Published As

Publication number Publication date
WO2007113241A1 (en) 2007-10-11
EP2383330A1 (en) 2011-11-02
EP2004789B1 (en) 2012-08-29

Similar Documents

Publication Publication Date Title
US8071345B2 (en) Stabilized subtilisin composition
WO2007113241A1 (en) A stabilized liquid enzyme composition
US11827866B2 (en) Stable enzyme solutions and method of manufacturing
EP2074205B2 (en) Detergent compositions and the use of enzyme combinations therein
EP1718724B1 (en) Enzyme stabilization in liquid detergents
JP2013116122A (en) Stabilization of concentrated liquid enzyme additive
WO2006131503A2 (en) Detergents with enzymatic builder and bleach systems
US20070060493A1 (en) Stabilization of concentrated liquid enzyme additives

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081031

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20090727

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 573111

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120915

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602007025109

Country of ref document: DE

Effective date: 20121025

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 573111

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120829

REG Reference to a national code

Ref country code: NL

Ref legal event code: VDEP

Effective date: 20120829

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

Effective date: 20120801

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20121229

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20121231

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20121130

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20121210

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20121129

26N No opposition filed

Effective date: 20130530

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602007025109

Country of ref document: DE

Effective date: 20130530

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130331

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130331

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130330

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20150309

Year of fee payment: 9

Ref country code: GB

Payment date: 20150325

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120829

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20130330

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20070330

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20160330

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20161130

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160331

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160330

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20210329

Year of fee payment: 15

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602007025109

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20221001